METEOR2

  • Research type

    Research Study

  • Full title

    The Meniscal Transplant surgery or Optimised Rehabilitation full randomised trial (MeTeOR2).

  • IRAS ID

    307686

  • Contact name

    Andrew Metcalfe

  • Contact email

    a.metcalfe@warwick.ac.uk

  • Sponsor organisation

    University of Warwick

  • ISRCTN Number

    ISRCTN87336549

  • Duration of Study in the UK

    5 years, 4 months, 30 days

  • Research summary

    The Meniscus is an important structure within the knee. One of its key roles is to cushion impact and protect the gliding surface of the joint from wear. Patients that have damaged their meniscus, and had a removal of the meniscus (a total meniscectomy), are more likely to develop persistent pain after this resulting in years of disability.

    At present, there are several treatment options ranging from knee therapy (physiotherapy) to a replacement meniscus also known as a ‘meniscal transplant’. Mensical transplant is thought to provide cushioning to the joint surfaces and improve symptoms but it has a long recovery period and the operation carries risk of surgery as well as not helping with symptoms. At present, there is no direct evidence that meniscal transplant is better of worse than a specific targeted rehabilitation and therapy program.

    In this study, we will compare two treatment for patients with a
    total meniscectomy. One group of patients will have a course of personalised knee therapy and the other group will have a meniscal transplant. In total a 144 participants will be recruited from 12 NHS Trust and 3 International sites
    and followed-up for 24 months post randomisation.

  • REC name

    London - Bloomsbury Research Ethics Committee

  • REC reference

    22/LO/0327

  • Date of REC Opinion

    22 Aug 2022

  • REC opinion

    Further Information Favourable Opinion